“Between 2002 and 2013 statin use in the US nearly doubled, cholesterol levels are falling, yet cardiovascular deaths appear to be on the rise.”
The science and policy of minimising risks associated with substance use, high-risk behaviours, and public health challenges — grounded in evidence rather than stigma.
